FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2910030724> ?p ?o ?g. }

• W2910030724 endingPage "1000" @default.
• W2910030724 startingPage "993" @default.
• W2910030724 abstract "Objectives: Epstein–Barr virus (EBV) has been implicated in lymphomagenesis of HIV-related classical Hodgkin lymphoma (HIV-cHL). The utility of EBV molecular and serological biomarkers has scarcely been examined in HIV-cHL in the recent combined antiretroviral therapy (cART) era. Design: We evaluated EBV DNA load and a panel of EBV antibodies in HIV-cHL patients prospectively enrolled in the French ANRS-CO16 Lymphovir cohort between 2008 and 2015. Methods: Pretreatment whole blood, plasma EBV DNA load and serological profiles were analysed in 63 HIV-infected patients diagnosed with cHL. For the 42 patients with available material, comparisons were performed between values at diagnosis and 6 months after the initiation of chemotherapy. Results: Pretreatment whole blood and plasma EBV DNA loads were positive in 84 and 59% of HIV-cHL patients, respectively. Two-year progression-free survival estimates did not differ between the patients with pretreatment whole blood (n = 53) or plasma (n = 37) EBV DNA(+) and the patients with pretreatment whole blood (n = 10) or plasma (n = 26) EBV DNA(−) (92 vs. 80% or 89 vs. 92%, P = 0.36 and 0.47, respectively). At diagnosis, 47% of patients harboured an EBV reactivation serological profile. Following chemotherapy, whole blood and plasma EBV DNA levels significantly declined from medians of 1570 [interquartile range, 230–3760) and 73 (0–320) copies/ml to 690 (0–1830) and 0 (0–0) copies/ml, respectively (P = 0.02 and P < 0.0001, respectively]. Anti-EBV IgG antibody level significantly dropped at 6-month follow-up (P = 0.004). Conclusion: Whole blood and plasma EBV DNA loads do not constitute prognostic markers in HIV-cHL patients in the modern cART era." @default.
• W2910030724 created "2019-01-25" @default.
• W2910030724 creator A5000636027 @default.
• W2910030724 creator A5006525776 @default.
• W2910030724 creator A5010229216 @default.
• W2910030724 creator A5011151101 @default.
• W2910030724 creator A5027882584 @default.
• W2910030724 creator A5039272561 @default.
• W2910030724 creator A5043265903 @default.
• W2910030724 creator A5043909607 @default.
• W2910030724 creator A5049427548 @default.
• W2910030724 creator A5051293408 @default.
• W2910030724 creator A5053365270 @default.
• W2910030724 creator A5067996191 @default.
• W2910030724 creator A5070084248 @default.
• W2910030724 creator A5073150851 @default.
• W2910030724 creator A5075809724 @default.
• W2910030724 creator A5080066537 @default.
• W2910030724 date "2019-05-01" @default.
• W2910030724 modified "2023-10-18" @default.
• W2910030724 title "Epstein–Barr virus biomarkers have no prognostic value in HIV-related Hodgkin lymphoma in the modern combined antiretroviral therapy era" @default.
• W2910030724 cites W1834515369 @default.
• W2910030724 cites W1967278331 @default.
• W2910030724 cites W1978253803 @default.
• W2910030724 cites W2041654996 @default.
• W2910030724 cites W2053361200 @default.
• W2910030724 cites W2067659752 @default.
• W2910030724 cites W2085732084 @default.
• W2910030724 cites W2088191643 @default.
• W2910030724 cites W2108311858 @default.
• W2910030724 cites W2108498499 @default.
• W2910030724 cites W2114897282 @default.
• W2910030724 cites W2115149722 @default.
• W2910030724 cites W2121128091 @default.
• W2910030724 cites W2129662814 @default.
• W2910030724 cites W2139016479 @default.
• W2910030724 cites W2141330149 @default.
• W2910030724 cites W2152942628 @default.
• W2910030724 cites W2161754043 @default.
• W2910030724 cites W2216756565 @default.
• W2910030724 cites W2282660120 @default.
• W2910030724 cites W2317464501 @default.
• W2910030724 cites W2319774285 @default.
• W2910030724 cites W2332905513 @default.
• W2910030724 cites W2339783666 @default.
• W2910030724 cites W2413353013 @default.
• W2910030724 cites W2529930251 @default.
• W2910030724 cites W2540234051 @default.
• W2910030724 cites W2610090714 @default.
• W2910030724 cites W2614048460 @default.
• W2910030724 cites W2755661484 @default.
• W2910030724 cites W2790652854 @default.
• W2910030724 cites W2890243347 @default.
• W2910030724 doi "https://doi.org/10.1097/qad.0000000000002129" @default.
• W2910030724 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30946153" @default.
• W2910030724 hasPublicationYear "2019" @default.
• W2910030724 type Work @default.
• W2910030724 sameAs 2910030724 @default.
• W2910030724 citedByCount "7" @default.
• W2910030724 countsByYear W29100307242020 @default.
• W2910030724 countsByYear W29100307242021 @default.
• W2910030724 countsByYear W29100307242023 @default.
• W2910030724 crossrefType "journal-article" @default.
• W2910030724 hasAuthorship W2910030724A5000636027 @default.
• W2910030724 hasAuthorship W2910030724A5006525776 @default.
• W2910030724 hasAuthorship W2910030724A5010229216 @default.
• W2910030724 hasAuthorship W2910030724A5011151101 @default.
• W2910030724 hasAuthorship W2910030724A5027882584 @default.
• W2910030724 hasAuthorship W2910030724A5039272561 @default.
• W2910030724 hasAuthorship W2910030724A5043265903 @default.
• W2910030724 hasAuthorship W2910030724A5043909607 @default.
• W2910030724 hasAuthorship W2910030724A5049427548 @default.
• W2910030724 hasAuthorship W2910030724A5051293408 @default.
• W2910030724 hasAuthorship W2910030724A5053365270 @default.
• W2910030724 hasAuthorship W2910030724A5067996191 @default.
• W2910030724 hasAuthorship W2910030724A5070084248 @default.
• W2910030724 hasAuthorship W2910030724A5073150851 @default.
• W2910030724 hasAuthorship W2910030724A5075809724 @default.
• W2910030724 hasAuthorship W2910030724A5080066537 @default.
• W2910030724 hasBestOaLocation W29100307241 @default.
• W2910030724 hasConcept C119060515 @default.
• W2910030724 hasConcept C126322002 @default.
• W2910030724 hasConcept C142462285 @default.
• W2910030724 hasConcept C159047783 @default.
• W2910030724 hasConcept C159654299 @default.
• W2910030724 hasConcept C1621761 @default.
• W2910030724 hasConcept C203014093 @default.
• W2910030724 hasConcept C2522874641 @default.
• W2910030724 hasConcept C2776694085 @default.
• W2910030724 hasConcept C2779338263 @default.
• W2910030724 hasConcept C2781375147 @default.
• W2910030724 hasConcept C45189115 @default.
• W2910030724 hasConcept C71924100 @default.
• W2910030724 hasConcept C90924648 @default.
• W2910030724 hasConceptScore W2910030724C119060515 @default.
• W2910030724 hasConceptScore W2910030724C126322002 @default.
• W2910030724 hasConceptScore W2910030724C142462285 @default.
• W2910030724 hasConceptScore W2910030724C159047783 @default.

• next